|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
GB8719963D0
(en)
|
1987-08-24 |
1987-09-30 |
Cattaneo A |
Recombinant dna products
|
|
US5831034A
(en)
|
1987-11-13 |
1998-11-03 |
Hermann Katinger |
Human monoclonal anti-HIV-I-antibodies
|
|
US5175384A
(en)
|
1988-12-05 |
1992-12-29 |
Genpharm International |
Transgenic mice depleted in mature t-cells and methods for making transgenic mice
|
|
DK0642585T3
(da)
|
1992-05-18 |
2006-05-15 |
Genentech Inc |
Aktiviering af oligomeriserende receptorer ved anvendelse af fusionerede receptorligander
|
|
US6476198B1
(en)
|
1993-07-13 |
2002-11-05 |
The Scripps Research Institute |
Multispecific and multivalent antigen-binding polypeptide molecules
|
|
UA40577C2
(uk)
|
1993-08-02 |
2001-08-15 |
Мерк Патент Гмбх |
Біспецифічна молекула, що використовується для лізису пухлинних клітин, спосіб її одержання, моноклональне антитіло (варіанти), фармацевтичний препарат, фармацевтичний набір (варіанти), спосіб видалення пухлинних клітин
|
|
AU697387C
(en)
|
1994-09-16 |
2006-03-02 |
Austin Research Institute Cancer and Anti-inflammatory Syndicate No 1 |
Polypeptides with Fc binding ability
|
|
US5874540A
(en)
|
1994-10-05 |
1999-02-23 |
Immunomedics, Inc. |
CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
|
|
IL111196A0
(en)
|
1994-10-07 |
1994-12-29 |
Yeda Res & Dev |
Peptides and pharmaceutical compositions comprising them
|
|
US6808709B1
(en)
*
|
1994-12-30 |
2004-10-26 |
The Regents Of The University Of California |
Immunoglobulins containing protection proteins and their use
|
|
US6165463A
(en)
*
|
1997-10-16 |
2000-12-26 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
MX9708008A
(es)
|
1995-04-19 |
1998-03-31 |
Polymun Scient Immunbio Forsch |
Anticuerpos monoclonales contra vih-1 y vacunas hechas de los mismos.
|
|
US20050003431A1
(en)
|
1996-08-16 |
2005-01-06 |
Wucherpfennig Kai W. |
Monovalent, multivalent, and multimeric MHC binding domain fusion proteins and conjugates, and uses therefor
|
|
US8212004B2
(en)
|
1999-03-02 |
2012-07-03 |
Human Genome Sciences, Inc. |
Neutrokine-alpha fusion proteins
|
|
US6045774A
(en)
*
|
1997-01-10 |
2000-04-04 |
Epicyte Pharmaceutical Inc. |
J chain polypeptide targeting molecule linked to an imaging agent
|
|
AU740918B2
(en)
*
|
1997-01-10 |
2001-11-15 |
Plantibodies Corporation |
Novel epithelial tissue targeting agent
|
|
US20040009166A1
(en)
|
1997-04-30 |
2004-01-15 |
Filpula David R. |
Single chain antigen-binding polypeptides for polymer conjugation
|
|
WO1999054484A1
(en)
|
1998-04-20 |
1999-10-28 |
The Regents Of The University Of California |
Modified immunoglobulin molecules and methods for use thereof
|
|
DE60043626D1
(de)
|
1999-01-07 |
2010-02-11 |
Zymogenetics Inc |
Verfahren zur therapeutischen Verwendung von löslichen rezeptoren BR43X2
|
|
WO2000061637A1
(en)
|
1999-04-14 |
2000-10-19 |
Smithkline Beecham Corporation |
Erythropoietin receptor antibodies
|
|
CA2375912C
(en)
|
1999-06-09 |
2014-03-11 |
Immunomedics, Inc. |
Immunotherapy of autoimmune disorders using antibodies which target b-cells
|
|
WO2001012820A1
(en)
|
1999-08-17 |
2001-02-22 |
Health Research Institute |
Genetic system and self-cleaving inteins derived therefrom, bioseparations and protein purification employing same, and methods for determining critical, generalizable amino acid residues for varying intein activity
|
|
IL148079A0
(en)
|
1999-08-24 |
2002-09-12 |
Medarex Inc |
Human ctla-4 antibodies and compositions containing the same
|
|
US20050287153A1
(en)
|
2002-06-28 |
2005-12-29 |
Genentech, Inc. |
Serum albumin binding peptides for tumor targeting
|
|
CN101289511A
(zh)
|
2000-04-11 |
2008-10-22 |
杰南技术公司 |
多价抗体及其应用
|
|
US20020168367A1
(en)
|
2000-04-28 |
2002-11-14 |
Planet Biotechnology Incorporated |
Novel immunoadhesins for treating and preventing viral and bacterial diseases
|
|
AU2001257445B2
(en)
|
2000-04-28 |
2006-11-02 |
Planet Biotechnology, Inc. |
Immunoadhesin for the prevention of rhinovirus infection
|
|
MXPA02011092A
(es)
*
|
2000-05-10 |
2004-08-19 |
David A Sirbasku |
Composiciones y metodos para demostrar la regulacion del sistema inmune secretor del crecimiento de la celula de cancer que responde a la hormona esteroidea.
|
|
CA2414272A1
(en)
|
2000-07-10 |
2002-01-17 |
Novartis Ag |
Bifunctional molecules and vectors complexed therewith for targeted gene delivery
|
|
JP2004514423A
(ja)
|
2000-09-07 |
2004-05-20 |
シュライバー， ジョン アール． |
トランスジェニックｘｅｎｏｍｏｕｓｅ（登録商標）から獲得されるｐｅｕｄｏｍｏｎａｓａｅｒｕｇｉｎｏｓａｌｐｓに対するヒト抗体
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US7138496B2
(en)
|
2002-02-08 |
2006-11-21 |
Genetastix Corporation |
Human monoclonal antibodies against human CXCR4
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
AU2002248571B2
(en)
|
2001-03-07 |
2007-01-18 |
Merck Patent Gmbh |
Expression technology for proteins containing a hybrid isotype antibody moiety
|
|
US7402312B2
(en)
|
2001-04-13 |
2008-07-22 |
Human Genome Sciences, Inc. |
Antibodies to vascular endothelial growth factor 2 (VEGF-2)
|
|
US20050129616A1
(en)
*
|
2001-05-25 |
2005-06-16 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to TRAIL receptors
|
|
NZ513418A
(en)
|
2001-08-07 |
2004-04-30 |
Univ Massey |
Vaccine comprising proteins from mycobacterium paratuberculosis
|
|
WO2003034903A2
(en)
|
2001-10-23 |
2003-05-01 |
Psma Development Company, L.L.C. |
Psma antibodies and protein multimers
|
|
KR101033196B1
(ko)
|
2002-02-14 |
2011-05-09 |
이뮤노메딕스, 인코오포레이티드 |
항-ｃｄ20 항체 및 그 융합 단백질 및 이들의 이용방법
|
|
US7282567B2
(en)
|
2002-06-14 |
2007-10-16 |
Immunomedics, Inc. |
Monoclonal antibody hPAM4
|
|
WO2003074566A2
(en)
|
2002-03-01 |
2003-09-12 |
Immunomedics, Inc. |
Rs7 antibodies
|
|
KR101017732B1
(ko)
|
2002-03-01 |
2011-02-28 |
이뮤노메딕스, 인코오포레이티드 |
내재화 항-ｃｄ74 항체 및 그 이용방법
|
|
BR0309254A
(pt)
*
|
2002-04-12 |
2005-03-01 |
Medarex Inc |
Uso de um anticorpo anti-ctla-4
|
|
US7601351B1
(en)
*
|
2002-06-26 |
2009-10-13 |
Human Genome Sciences, Inc. |
Antibodies against protective antigen
|
|
NZ537277A
(en)
|
2002-07-18 |
2008-04-30 |
Crucell Holland Bv |
Recombinant production of mixtures of antibodies
|
|
CA2494310A1
(en)
|
2002-08-01 |
2004-02-12 |
Immunomedics, Inc. |
Alpha-fetoprotein immu31 antibodies and fusion proteins and methods of use thereof
|
|
US20040156826A1
(en)
|
2002-09-27 |
2004-08-12 |
Fernando Dangond |
Treatment of patients with multiple sclerosis based on gene expression changes in central nervous system tissues
|
|
US7541440B2
(en)
|
2002-09-30 |
2009-06-02 |
Immunomedics, Inc. |
Chimeric, human and humanized anti-granulocyte antibodies and methods of use
|
|
US20050014932A1
(en)
*
|
2003-05-15 |
2005-01-20 |
Iogenetics, Llc |
Targeted biocides
|
|
AR044388A1
(es)
|
2003-05-20 |
2005-09-07 |
Applied Molecular Evolution |
Moleculas de union a cd20
|
|
EP1626992B1
(en)
|
2003-05-23 |
2010-06-02 |
Crucell Holland B.V. |
Production of recombinant igm in per.c6 cells
|
|
ATE490787T1
(de)
|
2003-07-15 |
2010-12-15 |
Chugai Pharmaceutical Co Ltd |
Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm- produktion
|
|
EP2216342B1
(en)
|
2003-07-31 |
2015-04-22 |
Immunomedics, Inc. |
Anti-CD19 antibodies
|
|
US8147832B2
(en)
|
2003-08-14 |
2012-04-03 |
Merck Patent Gmbh |
CD20-binding polypeptide compositions and methods
|
|
US7803914B2
(en)
|
2003-10-09 |
2010-09-28 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for stabilizing protein solutions
|
|
DE602004030811D1
(de)
*
|
2003-10-16 |
2011-02-10 |
Micromet Ag |
Multispezifische deimmunisierte cd3-bindende moleküle
|
|
FR2861255B1
(fr)
|
2003-10-24 |
2006-02-17 |
Centre Nat Rech Scient |
Mammifere non-humain transgenique pour la region constante de la chaine lourde des immunoglobulines humaines de classe a et ses applications.
|
|
EP1706425A2
(en)
|
2003-12-05 |
2006-10-04 |
John R. Schreiber |
Human anti-pseudomonas-aeruginosa antibodies derived from transgenic xenomouse®
|
|
US20050249723A1
(en)
|
2003-12-22 |
2005-11-10 |
Xencor, Inc. |
Fc polypeptides with novel Fc ligand binding sites
|
|
WO2005103081A2
(en)
|
2004-04-20 |
2005-11-03 |
Genmab A/S |
Human monoclonal antibodies against cd20
|
|
CN101098889A
(zh)
|
2004-11-05 |
2008-01-02 |
盘林京有限公司 |
抗体导致的细胞膜损伤
|
|
US7251164B2
(en)
|
2004-11-10 |
2007-07-31 |
Innovative Silicon S.A. |
Circuitry for and method of improving statistical distribution of integrated circuits
|
|
EP1833848A2
(en)
|
2004-12-09 |
2007-09-19 |
Lajolla Institute for Allergy and Immunology |
Novel tnf receptor regulatory domain
|
|
ES2665422T3
(es)
|
2005-03-03 |
2018-04-25 |
Immunomedics Inc. |
Anticuerpos L243 humanizados
|
|
US8349332B2
(en)
|
2005-04-06 |
2013-01-08 |
Ibc Pharmaceuticals, Inc. |
Multiple signaling pathways induced by hexavalent, monospecific and bispecific antibodies for enhanced toxicity to B-cell lymphomas and other diseases
|
|
KR20080031001A
(ko)
|
2005-06-02 |
2008-04-07 |
아스트라제네카 아베 |
Ｃｄ20에 대한 항체 및 그의 용도
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
AR056142A1
(es)
|
2005-10-21 |
2007-09-19 |
Amgen Inc |
Metodos para generar el anticuerpo igg monovalente
|
|
JP2009521474A
(ja)
*
|
2005-12-21 |
2009-06-04 |
メディミューン，エルエルシー |
ＥｐｈＡ２ＢｉＴＥ分子およびその使用
|
|
BRPI0711586A2
(pt)
|
2006-05-15 |
2011-11-16 |
Immunonomedics, Inc. |
método para tratamento de infecção por hiv em um indivìduo, método para imagem latente detectar ou diagnosticar a infecção por hiv em um indivìduo, composição
|
|
US8268635B2
(en)
|
2006-05-19 |
2012-09-18 |
Antonio Ferrante |
Methods of identifying agents that selectively activate p38 and/or NKkB signaling
|
|
WO2007146968A2
(en)
|
2006-06-12 |
2007-12-21 |
Trubion Pharmaceuticals, Inc. |
Single-chain multivalent binding proteins with effector function
|
|
CA2914170C
(en)
|
2006-09-08 |
2018-10-30 |
Abbvie Bahamas Ltd. |
Interleukin-13 binding proteins
|
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
|
CA2668208C
(en)
|
2006-11-02 |
2017-09-12 |
Daniel J. Capon |
Hybrid immunoglobulins with moving parts
|
|
US20080145420A1
(en)
|
2006-12-13 |
2008-06-19 |
Simon Michael R |
HUMAN SECRETORY IgA FOR THE TREATMENT OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASES
|
|
EP2087111A2
(en)
|
2007-03-19 |
2009-08-12 |
Medimmune Limited |
Polypeptide variants
|
|
WO2008135963A2
(en)
|
2007-05-02 |
2008-11-13 |
Hemogem Inc. |
Fibrinogen for treatment of bleeding in trauma and platelet disorders
|
|
WO2009013620A2
(en)
|
2007-06-11 |
2009-01-29 |
Erasmus University Medical Center Rotterdam |
Homologous recombination
|
|
EP2195342A1
(en)
|
2007-09-07 |
2010-06-16 |
Ablynx N.V. |
Binding molecules with multiple binding sites, compositions comprising the same and uses thereof
|
|
US8877688B2
(en)
|
2007-09-14 |
2014-11-04 |
Adimab, Llc |
Rationally designed, synthetic antibody libraries and uses therefor
|
|
CA2706700A1
(en)
|
2007-11-08 |
2009-05-14 |
Cytimmune Sciences, Inc. |
Compositions and methods for generating antibodies
|
|
EP2254592B1
(en)
|
2008-02-28 |
2019-06-05 |
Dako Denmark A/S |
Mhc multimers in borrelia diagnostics and disease
|
|
ITTO20080313A1
(it)
|
2008-04-22 |
2009-10-23 |
Marco Colombatti |
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi
|
|
WO2010006286A2
(en)
|
2008-07-11 |
2010-01-14 |
Sea Lane Biotechnologies, Llc |
Constructs and libraries comprising antibody surrogate kappa light chain sequences
|
|
WO2010037402A1
(en)
|
2008-10-02 |
2010-04-08 |
Dako Denmark A/S |
Molecular vaccines for infectious disease
|
|
DK2356270T3
(da)
|
2008-11-07 |
2016-12-12 |
Fabrus Llc |
Kombinatoriske antistofbiblioteker og anvendelser deraf
|
|
EP2509997B1
(en)
|
2009-12-07 |
2017-08-30 |
i2 Pharmaceuticals, Inc. |
Conjugates comprising an antibody surrogate scaffold with improved pharmacokinetic properties
|
|
CN102958942A
(zh)
|
2009-12-29 |
2013-03-06 |
新兴产品开发西雅图有限公司 |
异二聚体结合蛋白及其应用
|
|
TW201129384A
(en)
|
2010-02-10 |
2011-09-01 |
Immunogen Inc |
CD20 antibodies and uses thereof
|
|
WO2011100538A1
(en)
*
|
2010-02-11 |
2011-08-18 |
Alexion Pharmaceuticals, Inc. |
Therapeutic methods using an ti-cd200 antibodies
|
|
AU2011318567B2
(en)
|
2010-10-19 |
2017-02-09 |
Mayo Foundation For Medical Education And Research |
Human antibodies and diagnostic and therapeutic uses thereof for the treatment of neurological disease
|
|
WO2012088290A2
(en)
|
2010-12-22 |
2012-06-28 |
Abbott Laboratories |
Tri-variable domain binding proteins and uses thereof
|
|
AU2012328917B2
(en)
|
2011-10-24 |
2017-05-25 |
Abbvie Inc. |
Bispecific immunobinders directed against TNF and IL-17
|
|
GB201122047D0
(en)
|
2011-12-21 |
2012-02-01 |
Kymab Ltd |
Transgenic animals
|
|
US9253965B2
(en)
|
2012-03-28 |
2016-02-09 |
Kymab Limited |
Animal models and therapeutic molecules
|
|
WO2013087912A1
(en)
|
2011-12-16 |
2013-06-20 |
Synthon Biopharmaceuticals B.V. |
Compounds and methods for treating inflammatory diseases
|
|
TWI606064B
(zh)
|
2012-02-08 |
2017-11-21 |
Ｉｇｍ生物科技公司 |
細胞死亡誘導分子（ｃｄｉｍ）結合蛋白類及彼等之用途
|
|
EP3427747A1
(en)
|
2012-04-05 |
2019-01-16 |
Gottfried Himmler |
Secretory immunoglobulin complex
|
|
WO2013188870A2
(en)
|
2012-06-15 |
2013-12-19 |
Beth Israel Deaconess Medical Center, Inc. |
IgA CD4i ANTIBODIES AND METHODS OF TREATMENT USING SAME
|
|
CN104684928A
(zh)
|
2012-08-02 |
2015-06-03 |
Jn生物科学有限责任公司 |
通过半胱氨酸突变和μ尾端多聚化的抗体或融合蛋白
|
|
JOP20200236A1
(ar)
|
2012-09-21 |
2017-06-16 |
Regeneron Pharma |
الأجسام المضادة لمضاد cd3 وجزيئات ربط الأنتيجين ثنائية التحديد التي تربط cd3 وcd20 واستخداماتها
|
|
US10066238B2
(en)
|
2013-02-11 |
2018-09-04 |
University Of Louisville Research Foundation, Inc. |
Methods for producing antibodies
|
|
US9487773B2
(en)
|
2013-03-01 |
2016-11-08 |
Technophage, Investigacao E Desenvolvimento Em Biotecnologia, Sa |
Cell-based methods for coupling protein interactions and binding molecule selection
|
|
US20160152686A1
(en)
|
2013-03-13 |
2016-06-02 |
Bristol-Myers Squibb Company |
Fibronectin based scaffold domains linked to serum albumin or moiety binding thereto
|
|
GB201311487D0
(en)
*
|
2013-06-27 |
2013-08-14 |
Alligator Bioscience Ab |
Bispecific molecules
|
|
CA2917858A1
(en)
|
2013-08-02 |
2015-02-05 |
Aduro Biotech Holdings, Europe B.V. |
Combining cd27 agonists and immune checkpoint inhibition for immune stimulation
|
|
US20150038682A1
(en)
|
2013-08-02 |
2015-02-05 |
Jn Biosciences Llc |
Antibodies or fusion proteins multimerized via homomultimerizing peptide
|
|
JP6721505B2
(ja)
|
2013-09-05 |
2020-07-15 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
定常領域が修飾された（ｃｏｎｓｔａｎｔ ｃｈａｉｎ ｍｏｄｉｆｉｅｄ）二重特異性五価及び六価Ｉｇ−Ｍ抗体
|
|
WO2015037000A1
(en)
|
2013-09-11 |
2015-03-19 |
Compugen Ltd |
Vstm5 polypeptides and uses thereof as a drug for treatment of cancer, infectious diseases and immune related diseases
|
|
BR112016015140A2
(pt)
|
2013-12-30 |
2018-01-23 |
Epimab Biotherapeutics Inc. |
imunoglobulina com fabs in-tandem e usos das mesmas
|
|
SG10201806025TA
(en)
|
2014-01-16 |
2018-08-30 |
Mario Umberto Francesco Mondelli |
Neutralizing human monoclonal antibodies against hepatitis b virus surface antigen
|
|
JP2017512208A
(ja)
|
2014-02-10 |
2017-05-18 |
アイジーエム バイオサイエンス， インコーポレイテッド |
ＩｇＡ多重特異性結合分子
|
|
US20150259420A1
(en)
*
|
2014-03-14 |
2015-09-17 |
Novartis Ag |
Antibody molecules to lag-3 and uses thereof
|
|
IL292311A
(en)
*
|
2014-04-03 |
2022-06-01 |
Igm Biosciences Inc |
J-chain qualified
|
|
PT3247728T
(pt)
|
2015-01-20 |
2020-07-16 |
Igm Biosciences Inc |
Moléculas de ligação do recetor da superfamília do fator de necrose tumoral (fnt) e utilização das mesmas
|
|
KR102357312B1
(ko)
|
2015-03-04 |
2022-02-03 |
아이쥐엠 바이오사이언스 인코포레이티드 |
Ｃｄ20 결합 분자 및 그의 용도
|
|
WO2016154593A1
(en)
|
2015-03-25 |
2016-09-29 |
Igm Biosciences, Inc. |
Multi-valent hepatitis b virus antigen binding molecules and uses thereof
|
|
WO2016168758A1
(en)
|
2015-04-17 |
2016-10-20 |
Igm Biosciences, Inc. |
Multi-valent human immunodeficiency virus antigen binding molecules and uses thereof
|
|
FI3319936T3
(fi)
|
2015-07-12 |
2026-03-12 |
Hangzhou Dac Biotech Co Ltd |
Silloituslinkkereitä soluun sitoutuvien molekyylien konjugoimiseksi
|
|
EP3824903A1
(en)
|
2015-09-30 |
2021-05-26 |
IGM Biosciences Inc. |
Binding molecules with modified j-chain
|
|
EP3356401B1
(en)
|
2015-09-30 |
2020-06-24 |
IGM Biosciences, Inc. |
Binding molecules with modified j-chain
|
|
JP6979971B2
(ja)
|
2016-05-09 |
2021-12-15 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
抗ｐｄ−ｌ１抗体
|
|
AU2017300647A1
(en)
|
2016-07-20 |
2019-02-07 |
Igm Biosciences, Inc. |
Multimeric GITR binding molecules and uses thereof
|
|
JP2019530640A
(ja)
|
2016-07-20 |
2019-10-24 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
多量体ｏｘ４０結合分子及びその使用
|
|
EP3496536A4
(en)
|
2016-07-20 |
2020-02-12 |
IGM Biosciences, Inc. |
MULTIMERE CD40-BINDING MOLECULES AND USES THEREOF
|
|
EP3487298A4
(en)
|
2016-07-20 |
2020-03-11 |
IGM Biosciences, Inc. |
MULTIMERE CD137 / 4-1BB-BINDING MOLECULES AND USES THEREOF
|
|
US11401337B2
(en)
|
2017-04-07 |
2022-08-02 |
Igm Biosciences, Inc. |
Modified human IgM constant regions for modulation of complement-dependent cytolysis effector function
|
|
AU2019224136A1
(en)
|
2018-02-26 |
2020-09-10 |
Igm Biosciences, Inc. |
Use of a multimeric anti-DR5 binding molecule in combination with a chemotherapeutic agent for treating cancer
|
|
CN111787951B
(zh)
|
2018-03-01 |
2025-06-17 |
Igm生物科学股份有限公司 |
影响IgM血清半衰期的IgM Fc和J链突变
|
|
KR20210083260A
(ko)
|
2018-10-23 |
2021-07-06 |
아이쥐엠 바이오사이언스 인코포레이티드 |
다가 IgM- 및 IgA-Fc 기반 결합 분자
|
|
US20220106398A1
(en)
|
2019-02-08 |
2022-04-07 |
Igm Biosciences, Inc. |
Anti-gitr antigen-binding domains and uses thereof
|
|
MX2022001934A
(es)
|
2019-08-15 |
2022-03-11 |
Igm Biosciences Inc |
Moleculas de union multimericas inmunoestimuladoras.
|
|
WO2021034646A1
(en)
|
2019-08-17 |
2021-02-25 |
Igm Biosciences, Inc. |
Multimeric bispecific anti-cd123 binding molecules and uses thereof
|
|
KR20220050166A
(ko)
|
2019-08-23 |
2022-04-22 |
아이쥐엠 바이오사이언스 인코포레이티드 |
Igm 글리코변이체
|
|
CN114616031A
(zh)
|
2019-09-19 |
2022-06-10 |
Igm生物科学股份有限公司 |
对靶标密度高的细胞的选择性增强的多聚体抗体
|
|
IL293739A
(en)
|
2020-01-06 |
2022-08-01 |
Igm Biosciences Inc |
Highly sialic acid-modified multimeric binding compounds
|
|
BR112022021392A2
(pt)
|
2020-04-22 |
2022-12-06 |
Igm Biosciences Inc |
Moléculas de ligação multiméricas de agonista de pd-1
|
|
JP2023526224A
(ja)
|
2020-05-12 |
2023-06-21 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
がんを治療するための、がん治療薬との組合せでの多量体抗ｄｒ５結合分子の使用
|
|
EP4188951A4
(en)
|
2020-07-27 |
2024-08-28 |
IGM Biosciences, Inc. |
Multimeric coronavirus binding molecules and uses thereof
|
|
US20240002526A1
(en)
|
2020-11-17 |
2024-01-04 |
Igm Biosciences, Inc. |
Uses of effector cell engaging molecules with moieties of differing potencies
|
|
JP2024508709A
(ja)
|
2021-02-17 |
2024-02-28 |
アイジーエム バイオサイエンシズ インコーポレイテッド |
抗ｃｄ１２３結合分子及びその使用法
|
|
US20220267415A1
(en)
|
2021-02-17 |
2022-08-25 |
The Board Of Regents Of The University Of Texas System |
Multimeric sars-cov-2 binding molecules and uses thereof
|